Signals, Powered By EquityPandit
Orchid Pharma received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tamil Nadu.
Orchid Pharma in a filing to BSE stated, that the company has received EIR from the United States Food and Drug Administration(USFDA) on the basis of successful inspection of the active pharmaceuticals ingredients (API) manufacturing facility at Alathur.
